<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: RhoE, an atypical Rho protein, is differently deregulated in some <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, and there are conflicting data describing the role of RhoE in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor cell migration</z:e> and invasion </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to investigate RhoE expression in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and its relationship with clinicopathological features and prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues from 202 patients were examined by immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>Staining evaluation results were analyzed statistically in relation to various clinicopathological parameters, disease-free survival, and overall survival </plain></SENT>
<SENT sid="4" pm="."><plain>RhoE expression was also investigated by immunohistochemistry in 80 node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and the corresponding <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesions</z:e>, and by Western blot test in six <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>The relationship between RhoE and invasion was examined by transwell assay and Western blot test </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The positive rate for RhoE in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was significantly higher than that of <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal tissues </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, RhoE expression was significantly correlated with depth of invasion, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Consistently, overexpression of RhoE in SW620 cells up-regulated vimentin, down-regulated E-cadherin, increased the expression of matrix metalloproteinase (MMP) 9, and enhanced cell invasion in vitro; in contrast, silencing of RhoE by a specific siRNA caused opposite effects </plain></SENT>
<SENT sid="9" pm="."><plain>Most importantly, disease-free and overall survivals were significantly poorer for patients with RhoE-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than for those with RhoE-negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These findings emphasize the positive role of RhoE in invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>It could also serve as an independent prognostic marker in addition to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, node, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> staging system </plain></SENT>
</text></document>